About Adaptive Biotechnologies Adaptive Biotechnologies is a commercial-stage biotechnology company focused on translating the genetic language of the adaptive immune system into clinical products to diagnose and treat disease. Quick Links Stock Governance Filings Press Releases Adaptive Biotechnologies to Report Second Quarter Financial Results on August 4, 2021 07-12-2021 at 4:05 PM EDT New Study Published in Nature Provides Further Evidence that COVID-19 Vaccine Induced T-Cell Response Targets Known SARS-CoV-2 Variants of Concern 06-09-2021 at 7:15 AM EDT Adaptive Biotechnologies Included in More than 20 Abstracts at ASCO and EHA 2021 Highlighting Expanding Use Cases for MRD Testing with the clonoSEQ® Assay in Blood Cancer Patients 06-03-2021 at 7:30 AM EDT VIEW ALL NEWS Upcoming Events & Presentations Adaptive Biotechnologies Second Quarter Financial Results Aug 4, 2021 at 4:30 PM EDT Add to Outlook Add to Google Calendar Listen to webcast Past Events & Presentations Annual Shareholder Meeting Jun 11, 2021 Listen to webcast Goldman Sachs 42nd Annual Global Healthcare Conference Jun 8, 2021 at 12:50 PM PDT Listen to webcast William Blair 41st Annual Growth Stock Conference Jun 1, 2021 at 6:40 AM PDT Listen to webcast VIEW ALL EVENTS CHANGE VOLUME 52 week high 52 week LOW MARKET CAP Aug 3, 2021 1:38 PM EDTData Provided by Refinitiv. Minimum 15 minutes delayed.
